Navigation Links
Study shows answers for treating obesity-related diseases may reside in fat tissue
Date:7/4/2011

(Boston) Researchers at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have shown that the quality not just the quantity of adipose, or fat, tissue is a significant contributing factor in the development of inflammation and vascular disease in obese individuals. The study, which is a special feature on the iPAD version of the Journal of the American College of Cardiology, provides compelling evidence that the answer to treating cardiovascular disease and other obesity-related disorders, such as type 2 diabetes and cancer, might be found in the adipose tissue itself.

While obesity is a leading preventable cause of death in the United States, its prevalence continues to increase rapidly among individuals of all ethnicities and age groups. According to the National Institutes of Health, more than 33 percent of men and women above the age of 20 in the United States are obese and 68% are overweight.

Led by Noyan Gokce, MD, a cardiologist at BMC and an associate professor of medicine at BUSM, the researchers examined adipose tissue samples from both lean and obese individuals. The study subjects, all of whom were receiving care at BMC, included 109 obese men and women and 17 lean men and women between the ages of 21 and 55.

After obtaining the samples, the tissue was biopsied and evaluated for the amount of inflammation present in the tissue. They then performed a vascular ultrasound on the forearm artery to examine blood vessel function. After compiling the information, the researchers saw that lean individuals exhibited no adipose inflammation and normal vascular function whereas the obese individuals exhibited significant inflammation and poor vascular function.

While these study findings are consistent with other epidemiological obesity studies, this research team identified that 30 percent of the obese subjects demonstrated reduced fat inflammation, less insulin resistance, and their vascular function was similar to a lean person despite severe obesity. The study suggests that humans prone to inflammation in association with weight gain may be more susceptible to cardiovascular and metabolic disease risks.

"While it is widely believed that obesity and inflammation are linked to cardiovascular disease, this study shows not all obese individuals exhibit inflammation that can lead to cardiovascular disease, type 2 diabetes and cancer," said Gokce, the study's senior author. "Once we identify what harmful products adipose tissue is producing that is linked to causing systemic inflammation, we can explore treatments against it that could potentially combat the development of several debilitating obesity-related disorders."


'/>"/>

Contact: Jenny Eriksen
jenny.eriksen@bmc.org
617-947-0760
Boston University Medical Center
Source:Eurekalert

Related biology news :

1. Long-term study shows effect of climate change on animal diversity
2. £2 million study to reveal workings of dementia genes
3. New study looks to define evangelicals and how they affect polling
4. CU-Boulder study suggests air quality regulations miss key pollutants
5. Researchers study acoustic communication in deep-sea fish
6. Study reveals homeowner perceptions in fire-prone areas
7. Researchers study how pistachios may improve heart health
8. Study: urban black bears live fast, die young
9. New study indicates link between weight gains during pregnancy and dieting history
10. Study reveals specific gene in adolescent men with delinquent peers
11. Sweat it out: UH study examines ability of sweat patches to monitor bone loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, ... therapies for the treatment of bacterial infections, today ... of antibacterial candidates from Pro Bono Bio Ltd ... prevalence of multi-drug resistant forms of Gram-negative bacteria.  ... Anti Infectives Ltd, a PBB group company. ...
(Date:1/26/2017)... , Jan. 26, 2017  Crossmatch, a leading ... a new solution aimed at combatting fraud, waste and ... was introduced at the Action on Disaster Relief conference ... meeting point for UN agencies and foreign assistance organizations ... Fraud, waste and abuse are a largely unacknowledged problem ...
(Date:1/25/2017)... Jan. 25, 2017 The Elements of Enterprise ... lifecycle is comprised of a comprehensive set of ... of maintaining digital identities and providing a secured ... There are significant number of programs opted by ... time by optimizing processes and changing policies. However, ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... Symic Bio, a biopharmaceutical company focused on ... therapeutics, announced today the completion of enrollment for the ... The trial will evaluate the safety and efficacy of ... of restenosis following angioplasty. "We,re pleased ... said Nathan Bachtell , M.D., Chief Medical Officer ...
(Date:2/24/2017)... NY (PRWEB) , ... February 24, 2017 , ... FireflySci, ... Founded in late 2014, FireflySci had the goal of bringing their powerful ... goal continues to shape the path that FireflySci is going on as they add ...
(Date:2/24/2017)... -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing ... Leader event to highlight new clinical data that will ... the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and the Company,s ... in-person and via live webcast on Tuesday, February 28 ... the Lotte New York Palace Hotel in ...
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook Labs is formalizing a ... array of biochemical analyses critical for Lead Discovery. The company’s Lead Discovery ... programs, including inhibitor potency and selectivity, mechanism of action, and inhibitor residence times ...
Breaking Biology Technology: